Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL140 (C.i. 75300, Ci 75300, Ci-75300, C.i. natural yellow 3, Curcumin, Curcumin e100, Diferuloylmethane, E 100, E-100, E100, Haldar, INS-100(I), INS NO. 100(I), Jianghuangsu, Kacha haldi, Kurkum, Lipocurc, Merita earth, Nanocurc, NSC-32982, NSC-687842, Turmeric yellow) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| hydroxysteroid 11-beta dehydrogenase 1/11-beta-hydroxysteroid dehydrogenase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4235] [GtoPdb: 2763] [UniProtKB: P28845] | ||||||||
| ChEMBL | Inhibition of 11beta-HSD1 in human liver microsomes using [3H]-cortisone as substrate assessed as formation of cortisol after 60 to 90 mins by radiometric analysis | B | 4.8 | pIC50 | 15983 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 4362-4366 [PMID:23800686] |
| ChEMBL | Inhibition of human 11beta-HSD1 transfected in CHOP cells | B | 5.35 | pIC50 | 4501 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 4362-4366 [PMID:23800686] |
| ChEMBL | Inhibition of human 11beta-HSD1 incubated for 2 hrs | B | 5.64 | pIC50 | 2295 | nM | IC50 | Eur J Med Chem (2020) 191: 112134-112134 [PMID:32088493] |
| hydroxysteroid 11-beta dehydrogenase 1/11-beta-hydroxysteroid dehydrogenase 1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2391] [GtoPdb: 2763] [UniProtKB: P16232] | ||||||||
| ChEMBL | Inhibition of rat 11beta-HSD1 expressed in Leydig cells incubated for 2 hrs | B | 5.24 | pIC50 | 5785 | nM | IC50 | Eur J Med Chem (2020) 191: 112134-112134 [PMID:32088493] |
| ChEMBL | Inhibition of 11beta-HSD1 in rat testis microsomes using [3H]-11-DHC as substrate assessed as formation of CORT after 60 to 90 mins by radiometric analysis | B | 5.38 | pIC50 | 4125 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 4362-4366 [PMID:23800686] |
| ChEMBL | Inhibition of 11beta-HSD1 in Sprague-Dawley rat leydig cells at 100 uM | B | 5.41 | pIC50 | 3921 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 4362-4366 [PMID:23800686] |
| hydroxysteroid 11-beta dehydrogenase 2/11-beta-hydroxysteroid dehydrogenase type 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3746] [GtoPdb: 3143] [UniProtKB: P80365] | ||||||||
| ChEMBL | Inhibition of 11beta-HSD2 in human kidney microsomes using [3H]-cortisol as substrate assessed as formation of cortisone at 100 uM after 30 mins by radiometric analysis relative to control | B | 4.8 | pIC50 | 15696 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 4362-4366 [PMID:23800686] |
| ChEMBL | Inhibition of human 11beta-HSD2 incubated for 2 hrs | B | 4.84 | pIC50 | 14560 | nM | IC50 | Eur J Med Chem (2020) 191: 112134-112134 [PMID:32088493] |
| 11-beta-hydroxysteroid dehydrogenase type 2 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2908] [UniProtKB: P50233] | ||||||||
| ChEMBL | Inhibition of 11beta-HSD2 in rat kidney microsomes using [3H]-CORT as substrate assessed as formation of 11-DHC at 100 uM after 30 mins by radiometric analysis relative to control | B | 4.83 | pIC50 | 14939 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 4362-4366 [PMID:23800686] |
| hydroxysteroid 17-beta dehydrogenase 2/17-beta-hydroxysteroid dehydrogenase type 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2789] [GtoPdb: 3094] [UniProtKB: P37059] | ||||||||
| ChEMBL | Inhibition of human 17beta-HSD2 expressed in HEK293 cell lysates incubated for 10 mins using [2,4,6,7-3H]-estradiol and NAD+ by scintillation counting method | B | 5.76 | pIC50 | 1730 | nM | IC50 | J Nat Prod (2017) 80: 965-974 [PMID:28319389] |
| 17-beta-hydroxysteroid dehydrogenase type 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4234] [UniProtKB: P37058] | ||||||||
| ChEMBL | Inhibition of 17beta-HSD3 in human testis microsomes | B | 4.17 | pIC50 | 67300 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 2549-2551 [PMID:20346654] |
| 17-beta-hydroxysteroid dehydrogenase type 3 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075158] [UniProtKB: O54939] | ||||||||
| ChEMBL | Inhibition of 17beta-HSD3 in Sprague-Dawley rat laydig cells | B | 5.05 | pIC50 | 9000 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 2549-2551 [PMID:20346654] |
| ChEMBL | Inhibition of 17beta-HSD3 in Sprague-Dawley rat testis microsomes | B | 5.64 | pIC50 | 2300 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 2549-2551 [PMID:20346654] |
| Acetylcholinesterase in Electrophorus electricus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4078] [UniProtKB: O42275] | ||||||||
| ChEMBL | Inhibition of electric eel AChE using acetylcholine chloride as substrate preincubated for 15 mins by Ellman's method | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem (2011) 19: 7228-7235 [PMID:22041172] |
| ChEMBL | Inhibition of electric eel AChE using acetylthiocholine iodide as substrate after 15 mins by Ellman's method | B | 4.09 | pIC50 | 81050 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 2880-2882 [PMID:23583510] |
| acetylcholinesterase (Yt blood group)/Acetylcholinesterase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL220] [GtoPdb: 2465] [UniProtKB: P22303] | ||||||||
| ChEMBL | Inhibition of human erythrocyte AChE using acetylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method | B | 5.3 | pIC50 | >5000 | nM | IC50 | Eur J Med Chem (2017) 130: 139-153 [PMID:28242549] |
| synuclein alpha/Alpha-synuclein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6152] [GtoPdb: 3285] [UniProtKB: P37840] | ||||||||
| ChEMBL | Binding affinity to alpha-synuclein LMV 50 kDa (unknown origin) expressed in Escherichia coli BL21(DE3) cells incubated for 30 mins by spectrofluorometric analysis | B | 5.19 | pKd | 6500 | nM | Kd | Eur J Med Chem (2019) 167: 10-36 [PMID:30743095] |
| ChEMBL | Binding affinity to alpha-synuclein LMV 100 kDa (unknown origin) expressed in Escherichia coli BL21(DE3) cells incubated for 30 mins by spectrofluorometric analysis | B | 5.3 | pKd | 5000 | nM | Kd | Eur J Med Chem (2019) 167: 10-36 [PMID:30743095] |
| ChEMBL | Binding affinity to alpha-synuclein oligomer (unknown origin) expressed in Escherichia coli BL21(DE3) cells incubated for 30 mins by spectrofluorometric analysis | B | 5.7 | pKd | 2000 | nM | Kd | Eur J Med Chem (2019) 167: 10-36 [PMID:30743095] |
| ChEMBL | Binding affinity to alpha-synuclein preformed fibrils (unknown origin) expressed in Escherichia coli BL21(DE3) cells incubated for 30 mins by spectrofluorometric analysis | B | 6.3 | pKd | 500 | nM | Kd | Eur J Med Chem (2019) 167: 10-36 [PMID:30743095] |
| ChEMBL | Inhibition of alpha-Synuclein (unknown origin) aggregation incubated for 72 hrs by ThT-based fluorescence analysis | B | 5.48 | pIC50 | 3300 | nM | IC50 | Bioorg Med Chem (2023) 96: 117529-117529 [PMID:37976808] |
| ChEMBL | Inhibition of alpha-synuclein fibril formation (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay | B | 6.66 | pIC50 | 220 | nM | IC50 | Eur J Med Chem (2019) 167: 10-36 [PMID:30743095] |
| Monoamine oxidase A/Amine oxidase [flavin-containing] A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1951] [GtoPdb: 2489] [UniProtKB: P21397] | ||||||||
| ChEMBL | Inhibition of recombinant human MAO-A using p-tyramine as substrate assessed as H2O2 production preincubated for 15 mins followed by substrate addition measured for 15 mins by amplex red assay | B | 6.15 | pKi | 710 | nM | Ki | ACS Med Chem Lett (2016) 7: 56-61 [PMID:26819666] |
| ChEMBL | Inhibition of recombinant human MAOA using kynuramine as substrate by fluorescence based assay | B | 5.3 | pIC50 | 5020 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 127188-127188 [PMID:32299731] |
| ChEMBL | Inhibition of recombinant human MAO-A using using kynuramine as substrate assessed as inhibition of 4-hydroxyquinoline formation incubated for 20 mins by fluorescence spectrophotometric analysis | B | 5.56 | pIC50 | 2740 | nM | IC50 | Bioorg Med Chem Lett (2022) 77: 129038-129038 [PMID:36307034] |
| ChEMBL | Inhibition of human recombinant MAO-A assessed as inhibition of 4-hydroxyquinoline formation using kynuramine as substrate incubated for 20 mins by fluorescence spectrophotometry | B | 5.56 | pIC50 | 2740 | nM | IC50 | Bioorg Med Chem (2022) 73: 117030-117030 [PMID:36179486] |
| Monoamine oxidase B/Amine oxidase [flavin-containing] B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2039] [GtoPdb: 2490] [UniProtKB: P27338] | ||||||||
| ChEMBL | Inhibition of recombinant human MAO-B using p-tyramine as substrate assessed as H2O2 production preincubated for 15 mins followed by substrate addition measured for 15 mins by amplex red assay | B | 4.67 | pKi | 21500 | nM | Ki | ACS Med Chem Lett (2016) 7: 56-61 [PMID:26819666] |
| ChEMBL | Inhibition of recombinant human MAO-B using using kynuramine as substrate assessed as inhibition of 4-hydroxyquinoline formation incubated for 20 mins by fluorescence spectrophotometric analysis | B | 5.59 | pIC50 | 2580 | nM | IC50 | Bioorg Med Chem Lett (2022) 77: 129038-129038 [PMID:36307034] |
| ChEMBL | Inhibition of human recombinant MAO-B assessed as inhibition of 4-hydroxyquinoline formation using kynuramine as substrate incubated for 20 mins by fluorescence spectrophotometry | B | 5.59 | pIC50 | 2580 | nM | IC50 | Bioorg Med Chem (2022) 73: 117030-117030 [PMID:36179486] |
| ChEMBL | Inhibition of recombinant human MAOB using kynuramine as substrate by fluorescence based assay | B | 5.59 | pIC50 | 2560 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 127188-127188 [PMID:32299731] |
| Aminopeptidase N in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1907] [GtoPdb: 1560] [UniProtKB: P15144] | ||||||||
| ChEMBL | Inhibition of APN (unknown origin) | B | 4.81 | pIC50 | 15500 | nM | IC50 | J Med Chem (2018) 61: 6468-6490 [PMID:29630364] |
| ChEMBL | Inhibition of aminopeptidase N (unknown origin) | B | 5 | pIC50 | 10000 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 4948-4952 [PMID:23860593] |
| Aminopeptidase N in Pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2590] [UniProtKB: P15145] | ||||||||
| ChEMBL | Inhibition of pig microsomal aminopeptidase N using L-leu-p-nitroanilide as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by spectrophotometric analysis | B | 4.81 | pIC50 | 15500 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 4948-4952 [PMID:23860593] |
| Amyloid-beta precursor protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2487] [UniProtKB: P05067] | ||||||||
| ChEMBL | Displacement of [125I]IMSB from beta amyloid protein 40 | B | 9.68 | pKi | 0.21 | nM | Ki | J Med Chem (2006) 49: 6111-6119 [PMID:17004725] |
| ChEMBL | Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay | B | 4.61 | pIC50 | 24400 | nM | IC50 | J Nat Prod (2023) 86: 2162-2170 [PMID:37615114] |
| ChEMBL | Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method | B | 4.65 | pIC50 | 22510 | nM | IC50 | Eur J Med Chem (2017) 136: 36-51 [PMID:28478343] |
| ChEMBL | Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay | B | 4.66 | pIC50 | 21810 | nM | IC50 | Bioorg Med Chem (2016) 24: 3829-3841 [PMID:27353888] |
| ChEMBL | Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay | B | 4.66 | pIC50 | 21810 | nM | IC50 | Eur J Med Chem (2017) 125: 736-750 [PMID:27721157] |
| ChEMBL | Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by ThioflavinT staining based fluorescence assay | B | 4.69 | pIC50 | 20340 | nM | IC50 | RSC Med Chem (2024) 15: 2745-2765 [PMID:39149102] |
| ChEMBL | Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay | B | 4.69 | pIC50 | 20300 | nM | IC50 | Eur J Med Chem (2013) 69: 632-646 [PMID:24095756] |
| ChEMBL | Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay | B | 4.7 | pIC50 | >20000 | nM | IC50 | Eur J Med Chem (2021) 214: 113209-113209 [PMID:33548635] |
| ChEMBL | Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay | B | 4.7 | pIC50 | >20000 | nM | IC50 | Eur J Med Chem (2021) 214: 113209-113209 [PMID:33548635] |
| ChEMBL | Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay | B | 4.73 | pIC50 | 18730 | nM | IC50 | Eur J Med Chem (2017) 127: 174-186 [PMID:28061347] |
| ChEMBL | Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay | B | 4.73 | pIC50 | 18730 | nM | IC50 | Bioorg Med Chem (2018) 26: 5759-5765 [PMID:30360953] |
| ChEMBL | Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay | B | 4.74 | pIC50 | 18250 | nM | IC50 | Eur J Med Chem (2016) 122: 17-26 [PMID:27343850] |
| ChEMBL | Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method | B | 4.79 | pIC50 | 16250 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 127659-127659 [PMID:33137375] |
| ChEMBL | Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay | B | 4.82 | pIC50 | 14990 | nM | IC50 | Eur J Med Chem (2018) 151: 351-362 [PMID:29635167] |
| ChEMBL | Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method | B | 4.86 | pIC50 | 13700 | nM | IC50 | Medchemcomm (2018) 9: 1862-1870 [PMID:30568754] |
| ChEMBL | Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay | B | 4.91 | pIC50 | 12350 | nM | IC50 | J Med Chem (2013) 56: 5843-5859 [PMID:23799643] |
| ChEMBL | Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 10 hrs by thioflavin T based fluorometric assay | B | 4.95 | pIC50 | 11300 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 747-750 [PMID:26783181] |
| ChEMBL | Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay | B | 4.96 | pIC50 | 11000 | nM | IC50 | Bioorg Med Chem (2014) 22: 4784-4791 [PMID:25088549] |
| ChEMBL | Inhibition of human amyloid beta (1 to 42) aggregation after 46 to 48 hrs by Thioflavin T fluorescence assay | B | 5 | pIC50 | 10000 | nM | IC50 | J Nat Prod (2017) 80: 278-289 [PMID:28128562] |
| ChEMBL | Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method | B | 5 | pIC50 | 9900 | nM | IC50 | Eur J Med Chem (2017) 126: 823-843 [PMID:27951490] |
| ChEMBL | Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay | B | 5.05 | pIC50 | 9000 | nM | IC50 | Bioorg Med Chem Lett (2017) 27: 1405-1411 [PMID:28216401] |
| ChEMBL | Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay | B | 5.05 | pIC50 | 9000 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 3330-3335 [PMID:27256911] |
| ChEMBL | Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay | B | 5.08 | pIC50 | 8270 | nM | IC50 | Bioorg Med Chem (2021) 44: 116306-116306 [PMID:34274550] |
| ChEMBL | Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation | B | 5.19 | pIC50 | 6385 | nM | IC50 | Eur J Med Chem (2019) 180: 656-672 [PMID:31352246] |
| ChEMBL | Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay | B | 5.27 | pIC50 | 5400 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 5024-5028 [PMID:27624076] |
| ChEMBL | Inhibition of amyloid-beta (unknown origin) | B | 5.27 | pIC50 | 5400 | nM | IC50 | RSC Med Chem (2023) 14: 2535-2563 [PMID:38107170] |
| ChEMBL | Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay | B | 5.41 | pIC50 | 3900 | nM | IC50 | J Nat Prod (2015) 78: 1593-1599 [PMID:26099993] |
| ChEMBL | Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA | B | 5.41 | pIC50 | 3850 | nM | IC50 | Bioorg Med Chem (2021) 43: 116247-116247 [PMID:34157569] |
| ChEMBL | Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay | B | 5.47 | pIC50 | 3400 | nM | IC50 | Eur J Med Chem (2018) 158: 393-404 [PMID:30227353] |
| ChEMBL | Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method | B | 5.48 | pIC50 | 3300 | nM | IC50 | Eur J Med Chem (2017) 126: 823-843 [PMID:27951490] |
| ChEMBL | Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis | B | 5.51 | pIC50 | 3100 | nM | IC50 | ACS Med Chem Lett (2016) 7: 502-507 [PMID:27190601] |
| ChEMBL | Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis | B | 5.82 | pIC50 | 1500 | nM | IC50 | ACS Med Chem Lett (2016) 7: 502-507 [PMID:27190601] |
| ChEMBL | Inhibition of amyloid beta (1 to 40 residues) (unknown origin) fibril formation by thioflavin-T fluorescence based assay | B | 6 | pIC50 | 1000 | nM | IC50 | J Med Chem (2017) 60: 1620-1637 [PMID:28074653] |
| ChEMBL | Inhibition of amyloid beta 40 (unknown origin) assessed as disaggregation of fibrillar amyloid beta 40 incubated for 3 days by ELISA assay | B | 6 | pIC50 | 1000 | nM | IC50 | Eur J Med Chem (2021) 214: 113209-113209 [PMID:33548635] |
| ChEMBL | Inhibition of amyloid-beta (unknown origin) | B | 6 | pIC50 | <=1000 | nM | IC50 | Eur J Med Chem (2024) 270: 116333-116333 [PMID:38569434] |
| ChEMBL | Inhibition of amyloid beta (unknown origin) incubated for 7 days by sandwich ELISA | B | 6.05 | pIC50 | 900 | nM | IC50 | Eur J Med Chem (2021) 214: 113209-113209 [PMID:33548635] |
| ChEMBL | Inhibition of human amyloid beta (1 to 40) aggregation after 1 hr by thioflavin-T fluorescence assay | B | 6.1 | pIC50 | 800 | nM | IC50 | J Nat Prod (2017) 80: 278-289 [PMID:28128562] |
| ChEMBL | Inhibition of amyloid beta42 fibril formation by thioflavin T formation | B | 6.1 | pIC50 | 800 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 5591-5593 [PMID:18793854] |
| ChEMBL | Inhibition of amyloid beta 42 fibril formation by thioflavin T assay | B | 6.1 | pIC50 | 800 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 1466-1470 [PMID:17270435] |
| ChEMBL | Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by ThT fluorescence assay | B | 6.2 | pIC50 | 630 | nM | IC50 | Bioorg Med Chem (2017) 25: 1195-1201 [PMID:28043778] |
| ChEMBL | Inhibition of amyloid beta 42 transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay | B | 6.97 | pIC50 | 107 | nM | IC50 | Eur J Med Chem (2021) 214: 113209-113209 [PMID:33548635] |
| ABCB1/ATP-dependent translocase ABCB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4302] [GtoPdb: 768] [UniProtKB: P08183] | ||||||||
| ChEMBL | Inhibition of P-gp in human LS180 cells after 90 mins by rhodamine123 cell exclusion method | B | 4.21 | pIC50 | 62000 | nM | IC50 | Medchemcomm (2014) 5: 1540-1547 |
| ChEMBL | Inhibition of MDR1 (unknown origin) | B | 6 | pIC50 | <=1000 | nM | IC50 | Eur J Med Chem (2024) 270: 116333-116333 [PMID:38569434] |
| beta-secretase 1/Beta-secretase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4822] [GtoPdb: 2330] [UniProtKB: P56817] | ||||||||
| ChEMBL | Inhibition of beta-secretase using rhodamine-EVNLDAEFK-quencher as substrate after 60 mins by fluorescence resonance energy transfer assay | B | 5.24 | pIC50 | 5700 | nM | IC50 | Bioorg Med Chem (2012) 20: 6739-6750 [PMID:23041347] |
| ChEMBL | Inhibition of beta-secretase (unknown origin) using 150 nM Rhodamine-EVNLDAEFK-quencher substrate proteolysis by fluorescence resonance energy transfer assay | B | 5.28 | pIC50 | 5300 | nM | IC50 | Bioorg Med Chem (2014) 22: 4784-4791 [PMID:25088549] |
| ABCG2/Broad substrate specificity ATP-binding cassette transporter ABCG2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5393] [GtoPdb: 792] [UniProtKB: Q9UNQ0] | ||||||||
| ChEMBL | Inhibition of ABCG2 (unknown origin) expressed in human MCF7-VP cells mediated mitoxantrone efflux assessed as intracellular mitoxantrone level and measured after 45 mins by flow cytometry analysis | B | 5.79 | pIC50 | 1630 | nM | IC50 | Eur J Med Chem (2022) 237: 114346-114346 [PMID:35483322] |
| calcium/calmodulin-dependent protein kinase II alpha subunit/Calcium/calmodulin-dependent protein kinase type II subunit alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4147] [GtoPdb: 1555] [UniProtKB: Q9UQM7] | ||||||||
| ChEMBL | Inhibition of autophosphorylated alphaCaMK2 using GST-NR2A as substrate incubated for 1 min prior to substrate addition measured after 1 min | B | 4.35 | pIC50 | 45000 | nM | IC50 | Bioorg Med Chem (2012) 20: 6040-6047 [PMID:22989913] |
| ChEMBL | Inhibition of alphaCaMK2 T286D mutant using GST-NR2A as substrate incubated for 1 min prior to substrate addition measured after 1 min in presence of EGTA | B | 4.43 | pIC50 | 37000 | nM | IC50 | Bioorg Med Chem (2012) 20: 6040-6047 [PMID:22989913] |
| ChEMBL | Inhibition of autophosphorylated alphaCaMK2 using GST-NR2A as substrate incubated for 1 min prior to substrate addition measured after 1 min in presence of EGTA | B | 4.47 | pIC50 | 34000 | nM | IC50 | Bioorg Med Chem (2012) 20: 6040-6047 [PMID:22989913] |
| ChEMBL | Inhibition of alphaCaMK2 autophosphorylation at Thr286 using [gamma32P]ATP incubated for 30 secs prior to ATP addition measured after 30 secs | B | 4.48 | pIC50 | 33000 | nM | IC50 | Bioorg Med Chem (2012) 20: 6040-6047 [PMID:22989913] |
| ChEMBL | Inhibition of alphaCaMK2 using GST-NR2A as substrate incubated for 1 min prior to substrate addition measured after 1 min | B | 4.68 | pIC50 | 21000 | nM | IC50 | Bioorg Med Chem (2012) 20: 6040-6047 [PMID:22989913] |
| ChEMBL | Inhibition of alphaCaMK2 using GST-NR2A as substrate incubated for 1 min prior to substrate addition measured after 1 min | B | 4.89 | pIC50 | 13000 | nM | IC50 | Bioorg Med Chem (2012) 20: 6040-6047 [PMID:22989913] |
| carbonic anhydrase 1/Carbonic anhydrase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL261] [GtoPdb: 2597] [UniProtKB: P00915] | ||||||||
| ChEMBL | Inhibition of human carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration method | B | 5.62 | pKi | 2410 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5050-5053 [PMID:20674354] |
| carbonic anhydrase 12/Carbonic anhydrase 12 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3242] [GtoPdb: 2747] [UniProtKB: O43570] | ||||||||
| ChEMBL | Inhibition of human carbonic anhydrase 12 after 15 mins by stopped flow CO2 hydration method | B | 5.46 | pKi | 3480 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5050-5053 [PMID:20674354] |
| carbonic anhydrase 13/Carbonic anhydrase 13 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3912] [GtoPdb: 2748] [UniProtKB: Q8N1Q1] | ||||||||
| ChEMBL | Inhibition of human carbonic anhydrase 13 after 15 mins by stopped flow CO2 hydration method | B | 5.16 | pKi | 6850 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5050-5053 [PMID:20674354] |
| carbonic anhydrase 14/Carbonic anhydrase 14 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3510] [GtoPdb: 2598] [UniProtKB: Q9ULX7] | ||||||||
| ChEMBL | Inhibition of human carbonic anhydrase 14 after 15 mins by stopped flow CO2 hydration method | B | 4.93 | pKi | 11730 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5050-5053 [PMID:20674354] |
| Carbonic anhydrase 15 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5973] [UniProtKB: Q99N23] | ||||||||
| ChEMBL | Inhibition of mouse carbonic anhydrase 15 after 15 mins by stopped flow CO2 hydration method | B | 5.29 | pKi | 5090 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5050-5053 [PMID:20674354] |
| carbonic anhydrase 2/Carbonic anhydrase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL205] [GtoPdb: 3092] [UniProtKB: P00918] | ||||||||
| ChEMBL | Inhibition of human carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration method | B | 6.42 | pKi | 380 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5050-5053 [PMID:20674354] |
| Carbonic anhydrase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2885] [UniProtKB: P07451] | ||||||||
| ChEMBL | Inhibition of human carbonic anhydrase 3 after 15 mins by stopped flow CO2 hydration method | B | 4.95 | pKi | 11300 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5050-5053 [PMID:20674354] |
| carbonic anhydrase 4/Carbonic anhydrase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3729] [GtoPdb: 2599] [UniProtKB: P22748] | ||||||||
| ChEMBL | Inhibition of human carbonic anhydrase 4 after 15 mins by stopped flow CO2 hydration method | B | 5.3 | pKi | 4970 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5050-5053 [PMID:20674354] |
| carbonic anhydrase 5A/Carbonic anhydrase 5A, mitochondrial in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4789] [GtoPdb: 3093] [UniProtKB: P35218] | ||||||||
| ChEMBL | Inhibition of human carbonic anhydrase 5a after 15 mins by stopped flow CO2 hydration method | B | 4.99 | pKi | 10250 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5050-5053 [PMID:20674354] |
| Carbonic anhydrase 5B, mitochondrial in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3969] [UniProtKB: Q9Y2D0] | ||||||||
| ChEMBL | Inhibition of human carbonic anhydrase 5b after 15 mins by stopped flow CO2 hydration method | B | 5.02 | pKi | 9460 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5050-5053 [PMID:20674354] |
| Carbonic anhydrase 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3025] [UniProtKB: P23280] | ||||||||
| ChEMBL | Inhibition of human carbonic anhydrase 6 after 15 mins by stopped flow CO2 hydration method | B | 5 | pKi | 9940 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5050-5053 [PMID:20674354] |
| carbonic anhydrase 7/Carbonic anhydrase 7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2326] [GtoPdb: 2749] [UniProtKB: P43166] | ||||||||
| ChEMBL | Inhibition of human carbonic anhydrase 7 after 15 mins by stopped flow CO2 hydration method | B | 5.03 | pKi | 9300 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5050-5053 [PMID:20674354] |
| carbonic anhydrase 9/Carbonic anhydrase 9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3594] [GtoPdb: 3055] [UniProtKB: Q16790] | ||||||||
| ChEMBL | Inhibition of human carbonic anhydrase 9 after 15 mins by stopped flow CO2 hydration method | B | 5.39 | pKi | 4050 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 5050-5053 [PMID:20674354] |
| casein kinase 1 epsilon/Casein kinase I isoform epsilon in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4937] [GtoPdb: 1998] [UniProtKB: P49674] | ||||||||
| ChEMBL | Inhibition of recombinant human CK1epsilon expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| CDGSH iron-sulfur domain-containing protein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795168] [UniProtKB: Q9NZ45] | ||||||||
| ChEMBL | Displacement of [3H]rosiglitazone from recombinant human C-terminal His-tagged MitoNEET cytosolic domain (32 to 108 residues) expressed in Escherichia coli BL21 by Cheng-Prusoff analysis | B | 7 | pKi | 101 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 5350-5353 [PMID:27687671] |
| ChEMBL | Displacement of [3H]rosiglitazone from recombinant human C-terminal His-tagged MitoNEET cytosolic domain (32 to 108 residues) expressed in Escherichia coli BL21 by scintillation proximity assay | B | 5.63 | pIC50 | 2360 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 5350-5353 [PMID:27687671] |
| Cell division protein FtsZ in Bacillus subtilis (strain 168) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5690] [UniProtKB: P17865] | ||||||||
| ChEMBL | Inhibition of Bacillus subtilis FtsZ polymerization | B | 4.52 | pIC50 | 30000 | nM | IC50 | Eur J Med Chem (2010) 45: 4209-4214 [PMID:20615583] |
| butyrylcholinesterase/Cholinesterase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1914] [GtoPdb: 2471] [UniProtKB: P06276] | ||||||||
| ChEMBL | Inhibition of human serum BuChE using butylthiocholine chloride as substrate pretreated for 15 mins followed by substrate addition measured for 2 mins by DTNB reagent based spectrophotometric method | B | 5.3 | pIC50 | >5000 | nM | IC50 | Eur J Med Chem (2017) 130: 139-153 [PMID:28242549] |
| MMP13/Collagenase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL280] [GtoPdb: 1637] [UniProtKB: P45452] | ||||||||
| ChEMBL | Inhibition of human recombinant MMP13 expressed in Escherichia coli | B | 4.99 | pIC50 | 10300 | nM | IC50 | Bioorg Med Chem (2009) 17: 990-1005 [PMID:18358729] |
| CREB binding lysine acetyltransferase/CREB-binding protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5747] [GtoPdb: 2734] [UniProtKB: Q92793] | ||||||||
| ChEMBL | Inhibition of recombinant CBP (unknown origin) expressed in baculovirus expression system using histone substrate after 10 mins by liquid scintillation counting method in presence of [3H]acetyl-CoA | B | 4.6 | pIC50 | 25000 | nM | IC50 | J Med Chem (2016) 59: 1249-1270 [PMID:26701186] |
| cyclin dependent kinase 5/Cyclin-dependent kinase 5/CDK5 activator 1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907600] [GtoPdb: 1977] [UniProtKB: Q00535, Q15078] | ||||||||
| ChEMBL | Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| D-amino-acid oxidase in Pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6172] [UniProtKB: P00371] | ||||||||
| ChEMBL | Inhibition of porcine kidney DAAO using D-serine as substrate assessed as H2O2 formation by amplex red and peroxidase-coupled continuous fluorescence spectrophotometric analysis | B | 5.97 | pIC50 | 1070 | nM | IC50 | Bioorg Med Chem Lett (2022) 77: 129038-129038 [PMID:36307034] |
| ChEMBL | Inhibition of porcine kidney DAAO using D-serine as substrate by Amplex red and horseradish peroxidase fluorescence assay | B | 5.97 | pIC50 | 1070 | nM | IC50 | Bioorg Med Chem (2022) 73: 117030-117030 [PMID:36179486] |
| DNA methyltransferase 1/DNA (cytosine-5)-methyltransferase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1993] [GtoPdb: 2605] [UniProtKB: P26358] | ||||||||
| ChEMBL | Inhibition of DNMT1 (unknown origin) | B | 6 | pIC50 | <=1000 | nM | IC50 | Eur J Med Chem (2024) 270: 116333-116333 [PMID:38569434] |
| DNA topoisomerase II alpha/DNA topoisomerase 2-alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1806] [GtoPdb: 2637] [UniProtKB: P11388] | ||||||||
| ChEMBL | Inhibition of Homo sapiens (human) topoisomerase 2 assessed as decatenation of KDNA by agarose gel electrophoresis | B | 4.82 | pIC50 | 15000 | nM | IC50 | Med Chem Res (2012) 21: 874-890 |
| CDC like kinase 1/Dual specificity protein kinase CLK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4224] [GtoPdb: 1990] [UniProtKB: P49759] | ||||||||
| ChEMBL | Binding affinity to human CLK1 assessed as equilibrium dissociation constant measured upto 240 min by TR-FRET assay | B | 6 | pKd | >1000 | nM | Kd | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| ChEMBL | Inhibition of recombinant human CLK1 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| ChEMBL | Inhibition of recombinant human CLK1 expressed in Sf9 insect cells using myelin basic protein as substrate incubated for 110 mins in presence of ATP by non-radioactive ADP-Glo luminescence microplate reader assay | B | 5.31 | pIC50 | 4921 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| CDC like kinase 2/Dual specificity protein kinase CLK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4225] [GtoPdb: 1991] [UniProtKB: P49760] | ||||||||
| ChEMBL | Inhibition of recombinant human CLK2 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| CDC like kinase 3/Dual specificity protein kinase CLK3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4226] [GtoPdb: 1992] [UniProtKB: P49761] | ||||||||
| ChEMBL | Inhibition of recombinant human CLK3 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| CDC like kinase 4/Dual specificity protein kinase CLK4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4203] [GtoPdb: 1993] [UniProtKB: Q9HAZ1] | ||||||||
| ChEMBL | Inhibition of recombinant human CLK4 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5.01 | pIC50 | 9749 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| dual specificity tyrosine phosphorylation regulated kinase 1A/Dual specificity tyrosine-phosphorylation-regulated kinase 1A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2292] [GtoPdb: 2009] [UniProtKB: Q13627] | ||||||||
| ChEMBL | Binding affinity to human DYRK1A assessed as equilibrium dissociation constant measured upto 240 min by TR-FRET assay | B | 6 | pKd | >1000 | nM | Kd | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| ChEMBL | Inhibition of recombinant human DYRK1A expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| ChEMBL | Inhibition of recombinant human DYRK1A expressed in Escherichia coli using DYRKtide peptide as substrate incubated for 110 mins in presence of ATP by non-radioactive ADP-Glo luminescence microplate reader assay | B | 6.52 | pIC50 | 300 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| dual specificity tyrosine phosphorylation regulated kinase 1B/Dual specificity tyrosine-phosphorylation-regulated kinase 1B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5543] [GtoPdb: 2010] [UniProtKB: Q9Y463] | ||||||||
| ChEMBL | Inhibition of recombinant human DYRK1B expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| ChEMBL | Inhibition of recombinant human DYRK1B expressed in Sf9 insect cells using DYRKtide peptide as substrate incubated for 110 mins in presence of ATP by non-radioactive ADP-Glo luminescence microplate reader assay | B | 6.83 | pIC50 | 147.7 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| dual specificity tyrosine phosphorylation regulated kinase 2/Dual specificity tyrosine-phosphorylation-regulated kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4376] [GtoPdb: 2011] [UniProtKB: Q92630] | ||||||||
| ChEMBL | Binding affinity to DYRK2 (unknown origin) assessed as dissociation constant by SPR analysis | B | 4.84 | pKd | 14500 | nM | Kd | ACS Med Chem Lett (2024) 15: 659-666 [PMID:38746900] |
| ChEMBL | Inhibition of recombinant human DYRK2 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5.98 | pIC50 | 1058 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| ChEMBL | Inhibition of human recombinant DYRK2 using KKISGRLSPIMTEQ as substrate incubated for 60 mins in the presence of ATP by ADP-Glo kinase assay | B | 8 | pIC50 | 10 | nM | IC50 | ACS Med Chem Lett (2024) 15: 659-666 [PMID:38746900] |
| ChEMBL | Inhibition of N-terminal 6his tagged/ TEV fused full length human DYRK2 expressed in Escherichia coli BL21 (DE3) cells using KKISGRLSPIMTEQ as substrate incubated for 30 mins in presence of ATP | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2023) 66: 16235-16256 [PMID:38033250] |
| ChEMBL | Inhibition of human GST-tagged DYRK2 expressed in Escherichia coli BL21 (DE3) using woodtide as substrate in presence of [gamma33-P]ATP incubated for 30 mins by Scintillation counter analysis | B | 8.6 | pIC50 | 2.5 | nM | IC50 | J Med Chem (2023) 66: 4215-4230 [PMID:36800260] |
| dual specificity tyrosine phosphorylation regulated kinase 3/Dual specificity tyrosine-phosphorylation-regulated kinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4575] [GtoPdb: 2012] [UniProtKB: O43781] | ||||||||
| ChEMBL | Inhibition of recombinant human DYRK3 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5.37 | pIC50 | 4264 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| dual specificity tyrosine phosphorylation regulated kinase 4/Dual specificity tyrosine-phosphorylation-regulated kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075115] [GtoPdb: 2013] [UniProtKB: Q9NR20] | ||||||||
| ChEMBL | Inhibition of recombinant human DYRK4 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI in Escherichia coli (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1857] [UniProtKB: P0AEK4] | ||||||||
| ChEMBL | Inhibition of Escherichia coli MG1655 enoyl-ACP reductase overexpressed in Escherichia coli M15 assessed as oxidation of NADH to NAD+ after 5 mins | B | 4.83 | pKi | 14960 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 56-59 [PMID:19959361] |
| epidermal growth factor receptor/Epidermal growth factor receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
| ChEMBL | Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 μL of the test compounds and 10 μL solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 μL solution containing 20 mM HEPES, 2 mM MnCl2, 100 μM Na3VO4, 1 mM DTT buffer, and 20 μL of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 μL anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%−[(negative control)/(positive control−negative control)]. | B | 5.06 | pIC50 | 8650 | nM | IC50 | US-9409845-B2. Alpha-(3,5-dimethoxybenzylidene)-alpha′-hydrocarbyl methylene cyclic ketone and preparation method thereof (2016) |
| ChEMBL | Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry | B | 5.07 | pIC50 | 8600 | nM | IC50 | Bioorg Med Chem (2013) 21: 388-394 [PMID:23245570] |
| Glutathione-S-transferase in Schistosoma japonicum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4105850] [UniProtKB: Q26513] | ||||||||
| ChEMBL | Inhibition of Schistosoma japonicum GST by spectrophotometric analysis | B | 4.7 | pIC50 | >20000 | nM | IC50 | J Med Chem (2023) 66: 11118-11132 [PMID:37552553] |
| Glutathione S-transferase Mu 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4589] [UniProtKB: P28161] | ||||||||
| ChEMBL | Inhibition of human GSTM2 by spectrophotometric analysis | B | 5.74 | pIC50 | 1810 | nM | IC50 | J Med Chem (2023) 66: 11118-11132 [PMID:37552553] |
| glycogen synthase kinase 3 beta/Glycogen synthase kinase-3 beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL262] [GtoPdb: 2030] [UniProtKB: P49841] | ||||||||
| ChEMBL | Binding affinity to human GSK-3beta assessed as equilibrium dissociation constant measured upto 240 min by TR-FRET assay | B | 5 | pKd | >10000 | nM | Kd | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| ChEMBL | Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay | B | 4.75 | pIC50 | 17950 | nM | IC50 | J Med Chem (2016) 59: 531-544 [PMID:26696252] |
| ChEMBL | Inhibition of recombinant human GSK-3beta expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2023) 66: 4106-4130 [PMID:36876904] |
| glycogen synthase kinase 3 beta/Glycogen synthase kinase-3 beta in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3669] [GtoPdb: 2030] [UniProtKB: P18266] | ||||||||
| ChEMBL | Inhibition of recombinant rat N-terminal GST-tagged GSK3beta expressed in Escherichia coli assessed as reduction in tau phosphorylation preincubated for 30 mins followed by tau protein addition measured after 1 hr by ELISA | B | 7.18 | pIC50 | 66 | nM | IC50 | J Med Chem (2017) 60: 1620-1637 [PMID:28074653] |
| GroEL/GroES in Escherichia coli (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL4106139] [UniProtKB: Q548M1, Q7BGE6] | ||||||||
| ChEMBL | Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme activity using sodium mesoxalate as substrate after 20 to 40 mins by malachite green dye based spectrometric analysis | B | 5.51 | pIC50 | 3100 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 1106-1112 [PMID:30852084] |
| ChEMBL | Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity after 45 mins by Fe(SCN)3 dye based spectrometric analysis | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 1106-1112 [PMID:30852084] |
| Sodium/bile acid and sulphated solute cotransporter 1/Hepatic sodium/bile acid cotransporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5287] [GtoPdb: 959] [UniProtKB: Q14973] | ||||||||
| ChEMBL | Binding affinity to human NTCP assessed as dissociation constant by isothermal titration calorimetry | B | 4.19 | pKd | 64300 | nM | Kd | J Med Chem (2022) 65: 12546-12561 [PMID:36111355] |
| EP300 lysine acetyltransferase/Histone acetyltransferase p300 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3784] [GtoPdb: 2735] [UniProtKB: Q09472] | ||||||||
| ChEMBL | Inhibition of recombinant p300 | B | 4.4 | pIC50 | >40000 | nM | IC50 | Bioorg Med Chem (2009) 17: 1381-1386 [PMID:19114310] |
| ChEMBL | Inhibition of p300 HAT domain (unknown origin) using Biotin-C6-GRGKGGKGLGKGGAK as substrate pretreated with enzyme for 30 mins followed by incubation with substrate for 1 hr by radiometric scintillation proximity assay | B | 4.52 | pIC50 | 30000 | nM | IC50 | Nature (2017) 550: 128-132 [PMID:28953875] |
| GtoPdb | - | - | 4.6 | pIC50 | 25000 | nM | IC50 | J Biol Chem (2004) 279: 51163-71 [PMID:15383533] |
| ChEMBL | Inhibition of recombinant p300 (unknown origin) expressed in baculovirus expression system using histone substrate after 10 mins by liquid scintillation counting method in presence of [3H]acetyl-CoA | B | 4.6 | pIC50 | 25000 | nM | IC50 | J Med Chem (2016) 59: 1249-1270 [PMID:26701186] |
| ChEMBL | Inhibition of recombinant human full-length His6-tagged p300 expressed in baculovirus infected Sf21 insect cells using [3H]acetylCoA as substrate preincubated for 10 mins followed by substrate addition and measured after 10 mins by liquid scintillation counting method | B | 4.6 | pIC50 | 25000 | nM | IC50 | J Med Chem (2020) 63: 1337-1360 [PMID:31910017] |
| ChEMBL | Inhibition of P300 (unknown origin) using histone H3/[acetyl-3H]-acetyl coenzyme A as substrate | B | 5.19 | pIC50 | 6500 | nM | IC50 | J Med Chem (2015) 58: 2779-2798 [PMID:25730130] |
| ChEMBL | Inhibition of recombinant human p300 catalytic domain (1284 to 1673 residues) using histone H3 peptide substrate after 1 hr by liquid scintillation counting method in presence of [3H]acetyl-CoA | B | 5.19 | pIC50 | 6500 | nM | IC50 | J Med Chem (2016) 59: 1249-1270 [PMID:26701186] |
| histone acetyltransferase 1/Histone acetyltransferase type B catalytic subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523128] [GtoPdb: 2657] [UniProtKB: O14929] | ||||||||
| ChEMBL | Inhibition of HAT1 (unknown origin) | B | 6 | pIC50 | <=1000 | nM | IC50 | Eur J Med Chem (2024) 270: 116333-116333 [PMID:38569434] |
| histone deacetylase 1/Histone deacetylase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL325] [GtoPdb: 2658] [UniProtKB: Q13547] | ||||||||
| ChEMBL | Inhibition of HDAC1 (unknown origin) | B | 4.29 | pKi | 50790 | nM | Ki | Bioorg Med Chem Lett (2020) 30: 127171-127171 [PMID:32273215] |
| ChEMBL | Inhibition of human HDAC1 | B | 4.62 | pIC50 | 23810 | nM | IC50 | Eur J Med Chem (2023) 258: 115613-115613 [PMID:37399711] |
| histone deacetylase 2/Histone deacetylase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1937] [GtoPdb: 2616] [UniProtKB: Q92769] | ||||||||
| ChEMBL | Inhibition of HDAC2 (unknown origin) | B | 4.01 | pKi | 97670 | nM | Ki | Bioorg Med Chem Lett (2020) 30: 127171-127171 [PMID:32273215] |
| histone deacetylase 8/Histone deacetylase 8 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3192] [GtoPdb: 2619] [UniProtKB: Q9BY41] | ||||||||
| ChEMBL | Inhibition of HDAC8 (unknown origin) | B | 4.19 | pKi | 64980 | nM | Ki | Bioorg Med Chem Lett (2020) 30: 127171-127171 [PMID:32273215] |
| HSP60/HSP10 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL4106131] [UniProtKB: P10809, P61604] | ||||||||
| ChEMBL | Inhibition of human N-terminal octa-His-tagged HSP60 expressed in Escherichia coli Rosetta(DE3) pLysS/human HSP10 expressed in Escherichia coli Rosetta(DE3) assessed as reduction in HSP60/HSP10-mediated denatured MDH refolding by measuring MDH enzyme activity using sodium mesoxalate as substrate after 40 to 60 mins by malachite green dye based spectrometric analysis | B | 5.08 | pIC50 | 8300 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 1106-1112 [PMID:30852084] |
| Human immunodeficiency virus type 1 integrase in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3471] [UniProtKB: Q7ZJM1] | ||||||||
| ChEMBL | Inhibitory activity against HIV-1 integrase | B | 4.24 | pIC50 | 57500 | nM | IC50 | Bioorg Med Chem Lett (2000) 10: 1879-1882 [PMID:10969990] |
| ChEMBL | Inhibition of HIV1 integrase strand transfer activity | B | 4.4 | pIC50 | 40000 | nM | IC50 | J Nat Prod (2009) 72: 2019-2023 [PMID:19813754] |
| ChEMBL | Inhibition of HIV-1 integrase | B | 4.4 | pIC50 | 40000 | nM | IC50 | J Nat Prod (2013) 76: 1105-1112 [PMID:23742639] |
| ChEMBL | Inhibitory activity against HIV-1 Integrase (HIV-1-IN) | B | 4.52 | pIC50 | 30199.52 | nM | IC50 | J Med Chem (2002) 45: 841-852 [PMID:11831895] |
| ChEMBL | Compound concentration required to reduce HIV-1 Integrase 3'-processing activity by 50% | B | 4.52 | pIC50 | 30000 | nM | IC50 | J Med Chem (1998) 41: 3948-3960 [PMID:9767632] |
| ChEMBL | Inhibition of HIV1 integrase 3' processing activity | B | 4.52 | pIC50 | 30000 | nM | IC50 | J Nat Prod (2009) 72: 2019-2023 [PMID:19813754] |
| Lactoylglutathione lyase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2424] [UniProtKB: Q04760] | ||||||||
| ChEMBL | Inhibition of human glyoxalase 1 | B | 4.99 | pKi | 10300 | nM | Ki | Bioorg Med Chem Lett (2011) 21: 4243-4247 [PMID:21689932] |
| ChEMBL | Inhibition of human recombinant His-tagged glyoxalase 1 expressed in Escherichia coli BL21 (DE3) preincubated for 20 mins by Dixon plot analysis | B | 5 | pKi | 10000 | nM | Ki | Bioorg Med Chem (2011) 19: 1189-1196 [PMID:21237663] |
| ChEMBL | Inhibition of human erythrocyte Glyoxalase-1 using GSH and MGO as substrate by Dixon plot analysis | B | 8.3 | pKi | 5 | nM | Ki | Bioorg Med Chem (2020) 28: 115243-115243 [PMID:31879183] |
| Lipoxygenase in Glycine max (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1641359] [UniProtKB: Q39829] | ||||||||
| ChEMBL | Inhibition of soybean lipoxygenase after 5 mins by colorimetric assay | B | 4.23 | pIC50 | 59520 | nM | IC50 | Bioorg Med Chem (2014) 22: 4151-4161 [PMID:24938495] |
| lysine demethylase 1A/Lysine-specific histone demethylase 1A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6136] [GtoPdb: 2669] [UniProtKB: O60341] | ||||||||
| ChEMBL | Inhibition of human recombinant LSD1 using fluorogenic ADHP as substrate preincubated for 30 mins followed by substrate addition measured after 10 mins by fluorescence assay | B | 5.02 | pIC50 | 9600 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 126683-126683 [PMID:31627991] |
| MMP9/Matrix metalloproteinase-9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL321] [GtoPdb: 1633] [UniProtKB: P14780] | ||||||||
| ChEMBL | Reduction of MMP9 activity in TNF-alpha/IL1-beta-stimulated human Caco-2 cells treated 1 hr before stimulation by zymography | B | 5.07 | pIC50 | 8500 | nM | IC50 | Bioorg Med Chem (2009) 17: 1290-1296 [PMID:19128977] |
| Microtubule-associated protein tau in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293224] [UniProtKB: P10636] | ||||||||
| ChEMBL | Inhibition of tau (unknown origin) fibril formation by fluorescence assay | B | 4.89 | pIC50 | 13000 | nM | IC50 | J Med Chem (2017) 60: 1620-1637 [PMID:28074653] |
| ChEMBL | Inhibition of tau (unknown origin) fibril formation by thioflavin-T fluorescence based assay | B | 5.46 | pIC50 | 3500 | nM | IC50 | J Med Chem (2017) 60: 1620-1637 [PMID:28074653] |
| ChEMBL | Inhibition of recombinant human TAU three-repeat microtubule-binding domain aggregation expressed in Escherichia coli after 16 hrs by thioflavin T fluorescence assay | B | 5.52 | pIC50 | 3000 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 5024-5028 [PMID:27624076] |
| ChEMBL | Inhibition of tau phosphorylation (unknown origin) | B | 5.52 | pIC50 | 3000 | nM | IC50 | RSC Med Chem (2023) 14: 2535-2563 [PMID:38107170] |
| Multidrug resistance protein CDR1 in Candida albicans (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1163109] [UniProtKB: P43071] | ||||||||
| ChEMBL | Inhibition of GFP-tagged Candida albicans CDR1 expressed in Saccharomyces cerevisiae assessed as inhibition of R6G efflux | B | 4.4 | pIC50 | 40000 | nM | IC50 | Antimicrob Agents Chemother (2009) 53: 3256-3265 [PMID:19470507] |
| ChEMBL | Displacement of [125I]IAAP from GFP-tagged Candida albicans CDR1 expressed in Saccharomyces cerevisiae | B | 4.85 | pIC50 | 14200 | nM | IC50 | Antimicrob Agents Chemother (2009) 53: 3256-3265 [PMID:19470507] |
| NLRP3/NACHT, LRR and PYD domains-containing protein 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1741208] [GtoPdb: 1770] [UniProtKB: Q96P20] | ||||||||
| ChEMBL | Inhibition of NLRP3 inflammasome activation in LPS-primed human PMA-differentiated THP-1 cells assessed as reduction in nigericin-induced IL-1beta level preincubated for 30 mins followed by nigericin addition and measured after 1 hrs by Western blot analysis | B | 4.62 | pIC50 | 24200 | nM | IC50 | J Nat Prod (2020) 83: 2950-2959 [PMID:32989985] |
| Neuraminidase in Influenza A virus (strain A/USSR/90/1977 H1N1) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3559643] [UniProtKB: P03469] | ||||||||
| ChEMBL | Inhibition of recombinant Influenza A virus H1N1 neuraminidase using 4-methylumbelliferyl-alpha-D-Nacetylneuraminic acid sodium salt hydrate as substrate by fluorometry | B | 5 | pIC50 | 10000 | nM | IC50 | Bioorg Med Chem (2014) 22: 6047-6052 [PMID:25277281] |
| ChEMBL | Inhibition of Influenza A virus H5N1 neuraminidase using 4-methylumbelliferyl-alpha-D-Nacetylneuraminic acid sodium salt hydrate as substrate by fluorometry | B | 5.09 | pIC50 | 8100 | nM | IC50 | Bioorg Med Chem (2014) 22: 6047-6052 [PMID:25277281] |
| Inducible NOS/Nitric oxide synthase, inducible in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4481] [GtoPdb: 1250] [UniProtKB: P35228] | ||||||||
| ChEMBL | Inhibition of nitric oxide synthase in activated macrophages in human A431 cells | B | 5.22 | pIC50 | 6000 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 20523-20528 [PMID:18077363] |
| Inducible NOS/Nitric oxide synthase, inducible in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3464] [GtoPdb: 1250] [UniProtKB: P29477] | ||||||||
| ChEMBL | Inhibition of iNOS induction in mouse RAW264.7 cells assessed as NO production | B | 6.1 | pIC50 | 800 | nM | IC50 | J Med Chem (2014) 57: 6513-6530 [PMID:25058929] |
| nuclear factor, erythroid 2 like 2/Nuclear factor erythroid 2-related factor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075094] [GtoPdb: 3057] [UniProtKB: Q16236] | ||||||||
| ChEMBL | Activation of Nrf2 (unknown origin) expressed in human HepG2 cells after 5 hrs by ARE-driven luciferase reporter gene assay | B | 4.68 | pEC50 | 21000 | nM | EC50 | Eur J Med Chem (2018) 143: 854-865 [PMID:29223100] |
| ChEMBL | Activation of Nrf2 transcriptional activity in human LNCaP cells after 6 hrs by luciferase reporter gene assay relative to tert-butylhydroquinone | B | 5 | pEC50 | 9900 | nM | EC50 | J Med Chem (2014) 57: 5638-5648 [PMID:24920381] |
| nuclear factor kappa B subunit 1/nuclear factor kappa B subunit 2/RELA proto-oncogene, NF-kB subunit/Nuclear factor NF-kappa-B complex in Human (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL2094258] [GtoPdb: 3281, 3282, 3280] [UniProtKB: P19838, Q00653, Q04206] | ||||||||
| ChEMBL | Inhibition of TNFalpha-induced NF-kappaB transcriptional activity in human 5.1 cells after 6 hrs | B | 4.68 | pIC50 | 20900 | nM | IC50 | J Med Chem (2014) 57: 5638-5648 [PMID:24920381] |
| ChEMBL | Inhibition of NF-kappaB transactivation in TNF-alpha-stimulated human K562 cells preincubated for 2 hrs followed by TNF-alpha challenge measured after 6 hrs by dual luciferase reporter gene assay | B | 5.1 | pIC50 | 8000 | nM | IC50 | Bioorg Med Chem (2014) 22: 3008-3015 [PMID:24775915] |
| ChEMBL | Inhibition of NF-kappaB (unknown origin) | B | 6 | pIC50 | <=1000 | nM | IC50 | Eur J Med Chem (2024) 270: 116333-116333 [PMID:38569434] |
| nuclear factor kappa B subunit 1/Nuclear factor NF-kappa-B p105 subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3251] [GtoPdb: 3281] [UniProtKB: P19838] | ||||||||
| ChEMBL | Cellular Firefly Luciferase Assay (NFkB): The NF-kB activities of curcumin and analogs were determined by a cellular firefly luciferase assay. This assay utilized a commercially available cell line (Panomics 293T-luc cellular assay) developed for screening inhibitors of NF-kB. This cell line is stably transfected with a luciferase reporter controlled by an NF-kB dependent promoter. The cell is stimulated with tumor necrosis factor alpha (TNFalpha) which activates NF-kB. NF-kB then binds to one of six promoter regions on the cell's DNA leading to the production of a luciferase enzyme. Luciferin is added to the cell lysates and the luciferase enzyme catalyzes a cleavage of luciferin leading to the emission of light. | B | 5.09 | pIC50 | 8200 | nM | IC50 | US-9187397-B2. Therapeutic curcumin derivatives (2015) |
| Orphan methyltransferase M.SssI in Spiroplasma monobiae (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4373] [UniProtKB: P15840] | ||||||||
| ChEMBL | Inhibition of Spiroplasma sp. MQ-1 M.SssI | B | 7.52 | pIC50 | 30 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 706-709 [PMID:19112019] |
| Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
| ChEMBL | Antimalarial activity against chloroquine-resistant Plasmodium falciparum 7G8 | F | 4.53 | pIC50 | 29610 | nM | IC50 | Antimicrob Agents Chemother (2007) 51: 488-494 [PMID:17145789] |
| ChEMBL | Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 | F | 4.56 | pIC50 | 27450 | nM | IC50 | Antimicrob Agents Chemother (2007) 51: 488-494 [PMID:17145789] |
| ChEMBL | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 24 hrs by [3H]hypoxanthine labeling method | F | 4.6 | pIC50 | 25000 | nM | IC50 | Medchemcomm (2016) 7: 214-223 |
| ChEMBL | Antimalarial activity against chloroquine-susceptible Plasmodium falciparum D10 | F | 4.61 | pIC50 | 24690 | nM | IC50 | Antimicrob Agents Chemother (2007) 51: 488-494 [PMID:17145789] |
| ChEMBL | Antimalarial activity against chloroquine-susceptible Plasmodium falciparum D10 | F | 4.64 | pIC50 | 22930 | nM | IC50 | Antimicrob Agents Chemother (2007) 51: 488-494 [PMID:17145789] |
| ChEMBL | Antimalarial activity against chloroquine-resistant Plasmodium falciparum FCK by [3H]hypoxanthine uptake | F | 4.82 | pIC50 | 15000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 2453-2455 [PMID:19329310] |
| ChEMBL | Antimalarial activity against chloroquine-resistant Plasmodium falciparum MP14 | F | 5.38 | pIC50 | 4210 | nM | IC50 | Bioorg Med Chem (2008) 16: 2894-2902 [PMID:18194869] |
| ChEMBL | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCK2 | F | 5.49 | pIC50 | 3250 | nM | IC50 | Bioorg Med Chem (2008) 16: 2894-2902 [PMID:18194869] |
| 5-LOX/Polyunsaturated fatty acid 5-lipoxygenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL215] [GtoPdb: 1385] [UniProtKB: P09917] | ||||||||
| ChEMBL | Inhibition of human PMNL 5-LOX using arachidonic acid as substrate after 5 mins by HPLC method | B | 4.52 | pIC50 | 30000 | nM | IC50 | Bioorg Med Chem (2019) 27: 3745-3759 [PMID:31331653] |
| ChEMBL | Inhibition of 5LOX | B | 5.1 | pIC50 | 8000 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 20523-20528 [PMID:18077363] |
| ChEMBL | Inhibition of 5-LO in human neutrophils using arachidonic acid as substrate preincubated for 15 mins measured after 10 mins by HPLC analysis | B | 5.41 | pIC50 | 3900 | nM | IC50 | J Med Chem (2014) 57: 5638-5648 [PMID:24920381] |
| ChEMBL | Inhibition of 5-LO-mediated 5-HETE formation in LPS-stimulated human monocytes preincubated for 15 mins before arachidonic acid substrate addition measured after 30 mins by UPLC-MS/MS analysis | B | 6.22 | pIC50 | 600 | nM | IC50 | J Med Chem (2014) 57: 5638-5648 [PMID:24920381] |
| ChEMBL | Inhibition of 5-LO-mediated 5,12-DiHETE formation in LPS-stimulated human monocytes preincubated for 15 mins before arachidonic acid substrate addition measured after 30 mins by UPLC-MS/MS analysis | B | 6.22 | pIC50 | 600 | nM | IC50 | J Med Chem (2014) 57: 5638-5648 [PMID:24920381] |
| ChEMBL | Inhibition of 5-LO-mediated LTB4 formation in LPS-stimulated human monocytes preincubated for 15 mins before arachidonic acid substrate addition measured after 30 mins by UPLC-MS/MS analysis | B | 6.22 | pIC50 | 600 | nM | IC50 | J Med Chem (2014) 57: 5638-5648 [PMID:24920381] |
| ChEMBL | Inhibition of human recombinant 5-LO expressed in Escherichia coli Bl21 (DE3) using arachidonic acid as substrate preincubated for 10 mins measured after 10 mins by RP-HPLC analysis | B | 6.3 | pIC50 | 500 | nM | IC50 | J Med Chem (2014) 57: 5638-5648 [PMID:24920381] |
| 15-LOX-1/Polyunsaturated fatty acid lipoxygenase ALOX15 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2903] [GtoPdb: 1388] [UniProtKB: P16050] | ||||||||
| ChEMBL | Inhibition of 15-LO-mediated 15-HETE formation in LPS-stimulated human monocytes preincubated for 15 mins before arachidonic acid substrate addition measured after 30 mins by UPLC-MS/MS analysis | B | 5.92 | pIC50 | 1200 | nM | IC50 | J Med Chem (2014) 57: 5638-5648 [PMID:24920381] |
| Potassium channel subfamily K member 2 in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075183] [UniProtKB: Q8HY88] | ||||||||
| ChEMBL | Inhibition of TREK-1 K(+) channel in bovine AZF cells | B | 6.03 | pIC50 | 930 | nM | IC50 | J Nat Prod (2009) 72: 1533-1537 [PMID:19653644] |
| mPGES1/Prostaglandin E synthase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5658] [GtoPdb: 1377] [UniProtKB: O14684] | ||||||||
| ChEMBL | Inhibition of mPGES1-mediated PGE2 formation in LPS-stimulated human monocytes preincubated for 15 mins before arachidonic acid substrate addition measured after 30 mins by UPLC-MS/MS analysis | B | 5.92 | pIC50 | 1200 | nM | IC50 | J Med Chem (2014) 57: 5638-5648 [PMID:24920381] |
| ChEMBL | Inhibition of mPGES1-mediated PGE2 production in microsomes of IL-1beta stimulated human A549 cells preincubated for 15 mins by RP-HPLC analysis | B | 6.22 | pIC50 | 600 | nM | IC50 | J Med Chem (2014) 57: 5638-5648 [PMID:24920381] |
| ChEMBL | Inhibition of mPGES1 in human A549 cell microsomal membrane using pGH2 as substrate pretreated for 15 mins followed by substrate addition and measured after 1 min by RP-HPLC method | B | 6.52 | pIC50 | 300 | nM | IC50 | Eur J Med Chem (2018) 153: 2-28 [PMID:29329790] |
| ChEMBL | Inhibition of mPGES-1 in human IL-1beta-stimulated A549 cell microsomes assessed as reduction of PGE2 formation from PGH2 preincubated for 15 mins by HPLC analysis | B | 6.66 | pIC50 | 220 | nM | IC50 | J Nat Prod (2015) 78: 2867-2879 [PMID:26588603] |
| ChEMBL | Inhibition of microsomal PGES1 in ILbeta-stimulated human A549 cells using PGH2 as substrate preincubated for 15 mins followed by substrate addition measured after 1 min by RP-HPLC analysis | B | 6.7 | pIC50 | 200 | nM | IC50 | Medchemcomm (2015) 6: 2081-2123 |
| COX-1 /Prostaglandin G/H synthase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL221] [GtoPdb: 1375] [UniProtKB: P23219] | ||||||||
| ChEMBL | Inhibition of cyclooxygenase | B | 4.28 | pIC50 | 52000 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 20523-20528 [PMID:18077363] |
| ChEMBL | Inhibition of COX1 | B | 4.45 | pIC50 | 35090 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 1612-1616 [PMID:21345672] |
| ChEMBL | Inhibition of COX1 | B | 5.06 | pIC50 | 8800 | nM | IC50 | J Nat Prod (2005) 68: 985-991 [PMID:16038536] |
| ChEMBL | Inhibition of COX1-mediated PGE2 production in human platelets assessed as formation of 12-HHT using arachidonic acid as substrate preincubated for 5 mins measured after 5 mins by RP-HPLC analysis | B | 5.09 | pIC50 | 8100 | nM | IC50 | J Med Chem (2014) 57: 5638-5648 [PMID:24920381] |
| ChEMBL | Inhibition of COX-1 (unknown origin) | B | 6 | pIC50 | <=1000 | nM | IC50 | Eur J Med Chem (2024) 270: 116333-116333 [PMID:38569434] |
| Prostaglandin G/H synthase 1 in Sheep (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2949] [UniProtKB: P05979] | ||||||||
| ChEMBL | Inhibition of ovine COX1 using arachidonic acid substrate assessed as PGE2 production ELISA method after 2 mins | B | 4.53 | pIC50 | 29650 | nM | IC50 | Bioorg Med Chem (2014) 22: 4151-4161 [PMID:24938495] |
| COX-2 /Prostaglandin G/H synthase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL230] [GtoPdb: 1376] [UniProtKB: P35354] | ||||||||
| ChEMBL | Inhibition of human recombinant COX2 using arachidonic acid substrate assessed as PGE2 production ELISA method after 2 mins | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem (2014) 22: 4151-4161 [PMID:24938495] |
| ChEMBL | Inhibition of COX2 | B | 4.1 | pIC50 | 79200 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 1612-1616 [PMID:21345672] |
| ChEMBL | Anti-oxidant activity in DPPH radicak scavenging assay; n=3-4 | F | 4.96 | pIC50 | 11060 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 1793-1797 [PMID:15780608] |
| ChEMBL | Inhibition of COX-2 (unknown origin) | B | 6 | pIC50 | <=1000 | nM | IC50 | Eur J Med Chem (2024) 270: 116333-116333 [PMID:38569434] |
| Protease in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2366517] [UniProtKB: Q9YQ12] | ||||||||
| ChEMBL | Inhibition of HIV1 protease | B | 4 | pIC50 | 100000 | nM | IC50 | J Nat Prod (2009) 72: 2019-2023 [PMID:19813754] |
| ChEMBL | Inhibition of HIV-1 protease | B | 4 | pIC50 | 100000 | nM | IC50 | J Nat Prod (2013) 76: 1105-1112 [PMID:23742639] |
| proteasome 20S subunit beta 5/Proteasome Macropain subunit MB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4662] [GtoPdb: 2406] [UniProtKB: P28074] | ||||||||
| ChEMBL | Inhibition of chymotrypsin-like activity of human 26S proteasome in human HCT-116 cells assessed as decrease in AMC hydrolysis using Suc-LLVY-AMC as substrate preincubated for 24 hrs followed by addition of substrate and measured after 2 hrs by fluorometric analysis | B | 5 | pIC50 | 10000 | nM | IC50 | Eur J Med Chem (2019) 167: 291-311 [PMID:30776692] |
| ChEMBL | Inhibition of chymotrypsin-like activity of human 26S proteasome in human SW480 cells assessed as decrease in AMC hydrolysis using Suc-LLVY-AMC as substrate preincubated for 24 hrs followed by addition of substrate and measured after 2 hrs by fluorometric analysis | B | 5 | pIC50 | 10000 | nM | IC50 | Eur J Med Chem (2019) 167: 291-311 [PMID:30776692] |
| protein kinase C delta/Protein kinase C delta type in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2996] [GtoPdb: 1485] [UniProtKB: Q05655] | ||||||||
| ChEMBL | Binding affinity to GST-tagged PKCdelta expressed in Escherichia coli BL21(DE3) by fluorescence quenching | B | 4.97 | pEC50 | 10670 | nM | EC50 | Bioorg Med Chem (2010) 18: 1591-1598 [PMID:20100661] |
| protein kinase C epsilon/Protein kinase C epsilon type in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3582] [GtoPdb: 1486] [UniProtKB: Q02156] | ||||||||
| ChEMBL | Binding affinity to GST-tagged PKCepsilon expressed in Escherichia coli BL21(DE3) by fluorescence quenching | B | 5.06 | pEC50 | 8810 | nM | EC50 | Bioorg Med Chem (2010) 18: 1591-1598 [PMID:20100661] |
| protein kinase C theta/Protein kinase C theta type in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3920] [GtoPdb: 1488] [UniProtKB: Q04759] | ||||||||
| ChEMBL | Binding affinity to GST-tagged PKCtheta expressed in Escherichia coli BL21(DE3) by fluorescence quenching | B | 4.96 | pEC50 | 11080 | nM | EC50 | Bioorg Med Chem (2010) 18: 1591-1598 [PMID:20100661] |
| SRC proto-oncogene, non-receptor tyrosine kinase/Proto-oncogene tyrosine-protein kinase Src in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3074] [GtoPdb: 2206] [UniProtKB: P05480] | ||||||||
| ChEMBL | Inhibition of Src in mouse BV2 cells assessed as suppression of LPS-induced NO release preincubated for 1 hr followed by LPS addition measured after 24 hrs by Griess assay | B | 5.66 | pIC50 | 2200 | nM | IC50 | J Med Chem (2016) 59: 9062-9079 [PMID:27617803] |
| CoV 3C-like (main) protease/CoV Replicase polyprotein 1a/Replicase polyprotein 1a in Severe acute respiratory syndrome-related coronavirus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3927] [GtoPdb: 3111, 3124] [UniProtKB: P0C6U8] | ||||||||
| ChEMBL | Inhibition of SARS coronavirus 3CL protease | B | 4.4 | pIC50 | 40000 | nM | IC50 | J Med Chem (2007) 50: 4087-4095 [PMID:17663539] |
| CoV Replicase polyprotein 1ab/CoV RNA-dependent RNA polymerase/CoV Non-structural protein 15/Replicase polyprotein 1ab in Severe acute respiratory syndrome-related coronavirus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5118] [GtoPdb: 3125, 3139, 3206] [UniProtKB: P0C6X7] | ||||||||
| ChEMBL | Inhibition of 3C-like protease of SARS coronavirus assessed as concentration of FRET peptide for 60 mins | B | 4.63 | pIC50 | 23500 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 1873-1876 [PMID:20167482] |
| Rhodesain in Trypanosoma brucei rhodesiense (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4188] [UniProtKB: Q95PM0] | ||||||||
| ChEMBL | Inhibition of Trypanosoma brucei rhodesain using Cbz-Phe-Arg-AMC as substrate incubated for 30 mins by fluorometric assay | B | 5.11 | pIC50 | 7750 | nM | IC50 | ACS Med Chem Lett (2020) 11: 806-810 [PMID:32435388] |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 in Rabbit (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4693] [UniProtKB: P04191] | ||||||||
| ChEMBL | Inhibition of rabbit SERCA1b expressed in COS7 cells microsomal membranes preincubated for 10 mins followed by addition of ATP and measured after 40 mins by ELISA method | B | 5.24 | pKi | 5800 | nM | Ki | J Med Chem (2020) 63: 1937-1963 [PMID:32030976] |
| ChEMBL | Inhibition of rabbit skeletal muscle microsomes SERCA1a by enzyme-coupled method | B | 5.52 | pIC50 | 3000 | nM | IC50 | J Med Chem (2020) 63: 1937-1963 [PMID:32030976] |
| SERCA2/Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3901] [GtoPdb: 841] [UniProtKB: P16615] | ||||||||
| ChEMBL | Inhibition of human SERCA2b expressed in COS7 cells microsomal membranes preincubated for 10 mins followed by addition of ATP and measured after 40 mins by ELISA method | B | 4.28 | pKi | 53000 | nM | Ki | J Med Chem (2020) 63: 1937-1963 [PMID:32030976] |
| ChEMBL | Inhibition of SERCA2b in human platelet microsomes by enzyme-coupled method | B | 5.15 | pIC50 | 7000 | nM | IC50 | J Med Chem (2020) 63: 1937-1963 [PMID:32030976] |
| SERCA3/Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2401] [GtoPdb: 842] [UniProtKB: Q93084] | ||||||||
| ChEMBL | Inhibition of human SERCA3a expressed in COS7 cells microsomal membranes preincubated for 10 mins followed by addition of ATP and measured after 40 mins by ELISA method | B | 5.07 | pKi | 8600 | nM | Ki | J Med Chem (2020) 63: 1937-1963 [PMID:32030976] |
| ChEMBL | Inhibition of SERCA3 in human platelet microsomes by enzyme-coupled method | B | 5.15 | pIC50 | 7000 | nM | IC50 | J Med Chem (2020) 63: 1937-1963 [PMID:32030976] |
| p21 (RAC1) activated kinase 1/Serine/threonine-protein kinase PAK 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4600] [GtoPdb: 2133] [UniProtKB: Q13153] | ||||||||
| ChEMBL | Inhibition of recombinant human PAK1 by ADP-Glo kinase assay | B | 4.8 | pIC50 | 16000 | nM | IC50 | Eur J Med Chem (2017) 142: 229-243 [PMID:28814374] |
| signal transducer and activator of transcription 3/Signal transducer and activator of transcription 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4026] [GtoPdb: 2994] [UniProtKB: P40763] | ||||||||
| ChEMBL | Inhibition of STAT3 transcriptional activity in human HaCaT cells after 6 hrs by luciferase reporter gene assay | B | 4.47 | pIC50 | 33900 | nM | IC50 | J Med Chem (2014) 57: 5638-5648 [PMID:24920381] |
| ChEMBL | Inhibition of STAT3 in IL-6-stimulated human HepG2 cells treated for 1 hr prior to IL-6 challenge measured after 5.5 hrs by luciferase reporter gene assay | B | 4.72 | pIC50 | 19250 | nM | IC50 | Eur J Med Chem (2013) 62: 301-310 [PMID:23376248] |
| ChEMBL | Inhibition of IL-6-induced STAT3 pathway in human HepG2 cells by luciferase reporter gene assay | B | 4.72 | pIC50 | 19250 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 2225-2229 [PMID:23434226] |
| Sortase A in S.aureus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5362] [UniProtKB: Q9S446] | ||||||||
| ChEMBL | Inhibition of Staphylococcus aureus SrtA using EDANS-Dabcyl as substrate by FRET assay | B | 4.43 | pIC50 | 37500 | nM | IC50 | J Med Chem (2021) 64: 13097-13130 [PMID:34516107] |
| Sortase A in Streptococcus mutans (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523939] [UniProtKB: Q8CM62] | ||||||||
| ChEMBL | Binding affinity to Streptococcus mutans Sortase A | B | 4.99 | pIC50 | 10200 | nM | IC50 | Medchemcomm (2019) 10: 1057-1067 [PMID:31391878] |
| ChEMBL | Inhibition of recombinant Staphylococcus mutans UA159 SrtA using Dabcyl-QALPETGEE-Edans as substrate incubated for 1 hr by fluorometric analysis | B | 4.99 | pIC50 | 10200 | nM | IC50 | J Med Chem (2021) 64: 13097-13130 [PMID:34516107] |
| coagulation factor III, tissue factor/Tissue factor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4081] [GtoPdb: 3192] [UniProtKB: P13726] | ||||||||
| ChEMBL | Inhibition of tissue factor in Homo sapiens (human) THP1-cells using factor 10a chromogenic substrate assessed as inhibition of LPS-iduced procoagulant activity incubated for 1 hr prior to LPS-challenge measured after 5 hr by spectrophotometric analysis | B | 6.7 | pIC50 | 199.63 | nM | IC50 | Med Chem Res (2013) 22: 3242-3246 |
| ChEMBL | Inhibition of tissue factor procoagulant activity in LPS-stimulated human THP1 cells preincubated for 1 hr before LPS addition measured after 5 hrs | B | 6.7 | pIC50 | 199.63 | nM | IC50 | Bioorg Med Chem (2013) 21: 62-69 [PMID:23199480] |
| ChEMBL | Inhibition of LPS-induced tissue factor procoagulant activity in human THP1 cells preincubated for 1 hr followed by LPS addition measured after 5 hrs using factor 10a chromogenic substrate in presence of prothrombin complex | B | 7.88 | pIC50 | 13.16 | nM | IC50 | Bioorg Med Chem Lett (2017) 27: 1026-1030 [PMID:28109788] |
| TLR4/Toll-like receptor 4 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795167] [GtoPdb: 1754] [UniProtKB: Q9QUK6] | ||||||||
| ChEMBL | Inhibition of TLR4 in LPS-stimulated mouse RAW264.7 cells assessed as reduction of NO production after 24 hrs | B | 5.22 | pIC50 | 6000 | nM | IC50 | Bioorg Med Chem (2012) 20: 6073-6079 [PMID:22985959] |
| Transcription factor AP1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111421] [UniProtKB: P01100, P05412] | ||||||||
| ChEMBL | Inhibition of Fos-Jun dimer formation (unknown origin) | B | 8.16 | pIC50 | 6.9 | nM | IC50 | J Med Chem (2014) 57: 6930-6948 [PMID:24831826] |
| Transcription factor Jun in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4977] [UniProtKB: P05412] | ||||||||
| ChEMBL | Cellular Firefly Luciferase Assay (AP-1): Curcumin is a known inhibitor of the AP-1 activation cascade. Therefore, modification of the structure of curcumin could lead to analogs with enhanced activity. The library consisting of three series of curcumin analogs were used to examine the role of the enone functionality in aryl systems where the spacer is 7-carbons (as in curcumin), 5-carbons or 3-carbons in length. In addition, the importance of aryl ring substituents was assessed. The AP-1 activities of curcumin and analogs were determined by a cellular firefly luciferase assay. This assay utilized a commercially available cell line (Panomics 293-luc cellular assay) developed for screening inhibitors of AP-1. This cell line is stably transfected with a luciferase reporter controlled by an AP-1 dependent promoter. The cell is stimulated with phorbol ester which activates AP-1. AP-1 then binds to one of three promoter regions on the cells DNA leading to the production of a luciferase enzyme. Luciferin is added to the cell lysates and the luciferase enzyme catalyzes a cleavage of luciferin leading to the emission of light. | B | 4.89 | pIC50 | 12800 | nM | IC50 | US-9187397-B2. Therapeutic curcumin derivatives (2015) |
| Tubulin alpha 4a in Sheep (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2366421] [UniProtKB: C5ISA2] | ||||||||
| ChEMBL | Inhibition of Ovis aries (sheep) brain tubulin polymerization assessed as microtubule assembly after 15 min by measuring turbidity based spectroscopic analysis | B | 4.58 | pIC50 | 26600 | nM | IC50 | Med Chem Res (2011) 20: 503-510 |
| tyrosinase/Tyrosinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1973] [GtoPdb: 2643] [UniProtKB: P14679] | ||||||||
| ChEMBL | Inhibition of tyrosinase in human melanocyte cells using L-DOPA as substrate by absorbance method | B | 5.3 | pIC50 | 5000 | nM | IC50 | J Med Chem (2020) 63: 13428-13443 [PMID:32787103] |
| Vitamin D receptor/Vitamin D3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1977] [GtoPdb: 605] [UniProtKB: P11473] | ||||||||
| ChEMBL | Agonist activity at human VDR expressed in human HCT116 cells co-expressing VDRE assessed as XDR3 transcriptional activity after 24 hrs by luciferase reporter gene assay | B | 4.7 | pEC50 | 20000 | nM | EC50 | Bioorg Med Chem (2013) 21: 693-702 [PMID:23276449] |
| TRPV4 in Human [GtoPdb: 510] [UniProtKB: Q9HBA0] | ||||||||
| GtoPdb | - | - | 5.18 | pEC50 | 6600 | nM | EC50 | J Cardiovasc Transl Res (2019) 12: 600-607 [PMID:31664615] |
ChEMBL data shown on this page come from version 36:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]